Novartis Asks 4th Circ. To Block $1M Aredia, Zometa Verdict
Seeking to undo a $1.2 million verdict related to bone drugs Aredia and Zometa, Novartis Pharmaceuticals Corp. told the Fourth Circuit on Friday that a lower court erred when deciding what...To view the full article, register now.
Already a subscriber? Click here to view full article